⌘K
t
On 18 May 2026, Spire Healthcare Group plc's Executive Directors, Justin Ash and Harbant Samra, exercised vested nil-cost options under the company's share plans. Justin Ash exercised 547,061 shares from a 2021 Long Term Incentive Plan and 116,473 shares from a 2023 Deferred Share Bonus Plan, retaining 351,672 shares after tax, and now holds 1,652,131 ordinary shares. Harbant Samra exercised 37,463 shares from a 2023 Long Term Incentive Plan, retaining 19,855 shares after tax, bringing his total holding to 74,932 ordinary shares.
| Date | 19 May 2026 |
| Time | 15:28:54 |
| Category | Director/PDMR dealings |
| ID | 9608E |
Spire Healthcare Group plc (the Company)
Notification of Transactions of Persons Discharging Managerial Responsibilities
19 May 2026
Exercise of awards
The Company announces that, on 18 May 2026, the Executive Directors of the Company, exercised vested awards as follows:
(1) Justin Ash exercised both his:
· Long Term Incentive Plan awards in the Company that were granted on 18 March 2021 (the 2021 LTIP awards). 2021 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2023 Annual Report and Accounts. On vesting in March 2024, the 2021 LTIP awards were subject to a further two-year holding period which ended on 19 March 2026; and
· Deferred Share Bonus Plan awards that were granted on 15 March 2023 (the 2023 DSBP awards). 2023 DSBP awards were subject to a three-year holding period which ended on 15 March 2026; and
(2) Harbant Samra exercised his Long Term Incentive Plan awards in the Company that were granted on 15 March 2023 (the 2023 LTIP awards). 2023 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2025 Annual Report and Accounts.
Following the exercise by the Directors of these awards over ordinary shares in the Company and after the satisfaction of taxes due, both decided to retain the balance of ordinary shares as follows:
|
|
Share plan and type of award |
Shares vested and exercised |
Shares retained following satisfaction of taxes due |
|
Justin Ash |
2021 LTIP (in the form of nil-cost options)
|
547,061 |
289,942 |
|
Justin Ash
|
2023 DSBP (in the form of nil-cost options)
|
116,473 |
61,730 |
|
Total number of shares retained |
351,672 |
||
Following the transactions, Justin Ash holds 1,652,131 ordinary shares in the Company.
|
|
Share plan and type of award |
Shares vested and exercised |
Shares retained following satisfaction of taxes due |
|
Harbant Samra |
2023 LTIP (in the form of nil-cost options)
|
37,463 |
19,855 |
|
Total number of shares retained |
19,855 |
||
Following the transactions, Harbant Samra holds 74,932 ordinary shares in the Company.
Name of contact and telephone number for queries:
Mantraraj Budhdev
Group General Counsel, Chief People Officer and Company Secretary
Spire Healthcare Group plc
Tel: 07787 283848
Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name
|
Justin Ash |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status
|
Chief Executive Officer |
|
|
b) |
Initial notification /Amendment
|
Initial notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name
|
Spire Healthcare Group plc |
|
|
b) |
LEI |
213800IBJPW3SE2RA350 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1 pence each
GB00BNLPYF73 |
|
|
b) |
Nature of the transaction |
Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Long Term Incentive Plan.
Following the exercise by Mr Ash of his award over 547,061 ordinary shares and after the satisfaction of taxes due, a balance of 289,942 ordinary shares were transferred to him, which he has retained.
|
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
Nil
|
289,942 |
||
|
|
|||
|
d) |
Aggregated information - Aggregated volume - Price |
As above |
|
|
e) |
Date of the transaction |
2026-05-18 |
|
|
f) |
Place of the transaction |
Outside a trading venue |
|
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name
|
Justin Ash |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status
|
Chief Executive Officer |
|
|
b) |
Initial notification /Amendment
|
Initial notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name
|
Spire Healthcare Group plc |
|
|
b) |
LEI |
213800IBJPW3SE2RA350 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1 pence each
GB00BNLPYF73 |
|
|
b) |
Nature of the transaction |
Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Deferred Share Bonus Plan.
Following the exercise by Mr Ash of his award over 116,473 ordinary shares and after the satisfaction of taxes due, a balance of 61,730 ordinary shares were transferred to him, which he has retained.
|
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
Nil
|
61,730
|
||
|
|
|||
|
d) |
Aggregated information - Aggregated volume - Price |
As above |
|
|
e) |
Date of the transaction |
2026-05-18 |
|
|
f) |
Place of the transaction |
Outside a trading venue |
|
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name
|
Harbant Samra |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status
|
Chief Financial Officer |
|
|
b) |
Initial notification /Amendment
|
Initial notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name
|
Spire Healthcare Group plc |
|
|
b) |
LEI |
213800IBJPW3SE2RA350 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1 pence each
GB00BNLPYF73 |
|
|
b) |
Nature of the transaction |
Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Long Term Incentive Plan.
Following the exercise by Mr Samra of his award over 37,463 ordinary shares and after the satisfaction of taxes due, a balance of 19,855 ordinary shares were transferred to him, which he has retained.
|
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
Nil
|
19,855 |
||
|
|
|||
|
d) |
Aggregated information - Aggregated volume - Price |
As above |
|
|
e) |
Date of the transaction |
2026-05-18 |
|
|
f) |
Place of the transaction |
Outside a trading venue |
|